Pegcrisantaspase in Combination with Venetoclax for Treatment of Relapsed or Refractory Acute Myeloid Leukemia: A Phase 1 Study

被引：0
|
作者：
Niyongere, Sandrine [1 ,2 ]
Duong, Vu H. [2 ,3 ]
Bollino, Dominique R. [1 ]
Lapidus, Rena G. [1 ]
Strovel, Erin T. [4 ]
Zarrabi, Jinoos [1 ]
Bah, Osman Mohamed [1 ]
Philip, Sunita [1 ]
Kflu, Veronica [1 ]
Baer, Maria R. [2 ,3 ]
Emadi, Ashkan [1 ,2 ]
机构：
[1] Univ Maryland, Greenebaum Comprehens Canc Ctr, Baltimore, MD 21201 USA
[2] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA
[3] Univ Maryland, Greenebaum Canc Ctr, Baltimore, MD 21201 USA
[4] Univ Maryland, Sch Med, Dept Pediat, Baltimore, MD 21201 USA
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-150728
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4433
引用
收藏
页数：4
相关论文
共 50 条
  • [21] Venetoclax in Combination with Decitabine or Azacitidine in Relapsed or Refractory Acute Myeloid Leukemia Is Comparable to Alternative Regimens
    Miller, Jenn
    Shannon, Lindsey
    Finch, Amanda
    Altman, Jessica K.
    Wojenski, Daniel
    BLOOD, 2020, 136
  • [22] Venetoclax in Combination with Hypomethylating Agents Compared to Standard Chemotherapy in Relapsed/ Refractory Acute Myeloid Leukemia
    Mohassel, Leila
    Yakubi, Hanna
    Jones, Kendra
    Wang, Hongkun
    Shafer, Danielle
    BLOOD, 2022, 140 : 6158 - 6159
  • [23] Phase 1 study of selinexor in combination with salvage chemotherapy in Adults with relapsed or refractory Acute myeloid leukemia
    Bhatnagar, Bhavana
    Zhao, Qiuhong
    Mims, Alice S.
    Vasu, Sumithira
    Behbehani, Gregory K.
    Larkin, Karilyn
    Blachly, James S.
    Badawi, Mohamed A.
    Hill, Kasey L.
    Dzwigalski, Kyle R.
    Phelps, Mitch A.
    Blum, William
    Klisovic, Rebecca B.
    Ruppert, Amy S.
    Ranganathan, Parvathi
    Walker, Alison R.
    Garzon, Ramiro
    LEUKEMIA & LYMPHOMA, 2023, 64 (13) : 2091 - 2100
  • [24] RUNX1 mutations correlate with response to venetoclax combination therapies in relapsed/refractory acute myeloid leukemia
    Chow, Signy
    Tang, Kenny
    Al-Abri, Mahmood
    Hall, Victoria
    Tremblay-Lemay, Rosemarie
    Rashedi, Iran
    Tsui, Hubert
    Chan, Steven M.
    LEUKEMIA RESEARCH, 2021, 111
  • [25] Venetoclax in combination with hypomethylating agents or low dose cytarabine for relapsed and refractory acute myeloid leukemia
    Graveno, Molly E.
    Carulli, Alison
    Freyer, Craig W.
    Mangan, Brendan L.
    Nietupski, Robert
    Loren, Alison W.
    Frey, Noelle, V
    Porter, David L.
    Gill, Saar, I
    Hexner, Elizabeth O.
    Luger, Selina M.
    Martin, Mary Ellen
    McCurdy, Shannon R.
    Perl, Alexander E.
    Babushok, Daria, V
    Pratz, Keith W.
    LEUKEMIA & LYMPHOMA, 2022, 63 (07) : 1645 - 1650
  • [26] Overcoming Venetoclax (Ven) Resistance through Glutamine (Gln) Depletion: Final Analysis of the Phase 1 Trial of Ven and Pegcrisantaspase (PegC) Combination in Relapsed and Refractory (R/R) Acute Myeloid Leukemia (AML)
    Liu, Yuchen
    Bollino, Dominique
    Bah, Osman M.
    Strovel, Erin T.
    Zarrabi, Jinoos
    Philip, Sunita
    Mostafa, Ezzat
    Lapidus, Rena G.
    Baer, Maria R.
    Niyongere, Sandrine
    Duong, Vu H.
    Dougherty, Christine C.
    Caprinolo, Katherine
    Emadi, Ashkan
    BLOOD, 2023, 142
  • [27] COMBINATION OF CLOFARABINE AND CYTARABINE IN THE TREATMENT OF REFRACTORY OR RELAPSED ACUTE MYELOID LEUKEMIA
    Spassov, B.
    Balatzenko, G.
    Angelova, S.
    Toshkov, S.
    Guenova, M.
    Arnaudov, G.
    Mihaylov, G.
    HAEMATOLOGICA, 2015, 100 : 377 - 377
  • [28] Venetoclax in Relapsed/Refractory Acute Myeloid Leukemia: Are Supporting Evidences Enough?
    Brancati, Serena
    Gozzo, Lucia
    Romano, Giovanni Luca
    Vetro, Calogero
    Dulcamare, Ilaria
    Maugeri, Cinzia
    Parisi, Marina
    Longo, Laura
    Vitale, Daniela Cristina
    Di Raimondo, Francesco
    Drago, Filippo
    CANCERS, 2022, 14 (01)
  • [29] Treatment for Relapsed/Refractory Acute Myeloid Leukemia
    Thol, Felicitas
    Heuser, Michael
    HEMASPHERE, 2021, 5 (06): : E572
  • [30] CPX-351 with Venetoclax in Patients with Relapsed/Refractory Acute Myeloid Leukemia: Results of a Phase Ib Study
    Bataller, Alex
    Bazinet, Alexandre
    Borthakur, Gautam
    Short, Nicholas J.
    Jabbour, Elias
    Takahashi, Koichi
    Daver, Naval
    Issa, Ghayas C.
    DiNardo, Courtney D.
    Pemmaraju, Naveen
    Jain, Nitin
    Montalban-Bravo, Guillermo
    Wierda, William G.
    Ravandi, Farhad
    Kantarjian, Hagop M.
    Kadia, Tapan M.
    BLOOD, 2023, 142
12345